News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
Italy Antitrust Probes Pfizer Inc. Over Xalatan
October 28, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ROME, Oct 26 (Reuters) - Pfizer Inc: * Italy antitrust says opening probe into Pfizer Inc for abuse of market position over xalatan drug (Rome newsroom, +39 06 8522 4350) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Europe
Pfizer
MORE ON THIS TOPIC
Drug pricing
Trump’s Drug Pricing Order ‘More Bark Than Bite’
May 12, 2025
·
5 min read
·
Annalee Armstrong
Drug pricing
White House Unwraps Massive Drug Pricing Policy, Touching All Corners of Pharma
May 12, 2025
·
6 min read
·
Annalee Armstrong
Legal
BMS, Sanofi Settle Plavix Suit With Hawaii for $700M
May 12, 2025
·
2 min read
·
Tristan Manalac
Vaccines
FDA, EU Flag Safety Issues With Valneva’s Chikungunya Vaccine
May 12, 2025
·
2 min read
·
Tristan Manalac
